Lupin share price

ABOUT Lupin

• Industry Biotechnology & Drugs
• ISIN INE326A01037
• BSE Code 500257
• NSE Code LUPIN

Lupin Limited is an India-based innovation-led transnational pharmaceutical company. The Company develops and commercializes a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions. The Company has a presence in the cardiovascular, anti-diabetic, and respiratory segments and has a significant presence in the anti-infective, gastro-intestinal (GI), central nervous system (CNS), and others. Its complex generics portfolio includes Filgrastim, Pegfilgrastim, Etanercept and Albuterol and others. Its biosimilar products include Lupifil (Filgrastim), Lupifil-P (Peg-Filgrastim) and Etanercept. Its diabetes brands include ONDERO and ONDERO MET. The Company has 15 manufacturing sites, seven research centers, and more than 20,000 professionals working globally.

Lupin Management

• Vinita Gupta Chief Executive Officer, Executive Director
• Ramesh Swaminathan Executive Director, Global Chief Financial Officer, Chief Risk Officer, Head - Corporate Affairs
• Rajendra Chunodkar President - Manufacturing Operations
• Fabrice Egros President - Corporate Development and Growth Markets
• Shahin Fesharaki President - Global Chief Scientific Officer
• Spiro Gavaris President - U.S. Generics
• Naresh Gupta President - API Plus and Global TB
• Rajender Kamboj President - Novel Drug Discovery and Development
• Cyrus Karkaria President - Biotechnology
• Yashwant Mahadik President - Global Human Resources